About This Course

An expert panel of multidisciplinary authors have designed this course to help European hospital directors decide whether to utilize next-generation sequencing in-house or outsource to an external provider.

Duration: This course should take approximately 60 minutes to complete. It can be completed in one or multiple sessions.

The creation of this course was sponsored by Thermo Fisher Scientific. The sponsor had no role in design, content selection, preparation, or delivery of the course.

This course has been approved for 1 CPD point by the Royal College of Pathologists.

This course has a 2-year expiry date of 15th May 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed. 

Learning Objectives

  • You will know how to reach an evidence-based decision on whether to invest in and promote next-generation sequencing (NGS) in your hospital.

  • You will be able to anticipate and discuss genuine concerns clinicians have around the necessity, accuracy and value of NGS.

Expert Faculty

Course curriculum

    1. Disclosures

    1. Navigation Instructions

    2. About you

    1. Main Course

    1. Introduction to Final Quiz

    2. Final Quiz

    1. Course Feedback Survey

About this course

  • Free
  • 7 lessons
  • 0 hours of video content